Identifying factors affecting outcomes in heart surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to identify factors that contribute to perioperative morbidity and mortality in patients undergoing cardiac surgery involving cardiopulmonary bypass. It will analyze demographic data, perioperative medications, and comorbidities among patients who had cardiovascular surgeries at UC Davis Medical Center over a 12-year period. By understanding these factors, the study seeks to improve patient outcomes in cardiac surgery.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Patients greater than or equal to 18 years old that underwent cardiovascular surgery at UC Davis Medical Center from 01/01/2001 to 07/15/2013.

Patients will only be included that underwent cardiovascular surgeries with or without cardiopulmonary bypass.

Exclusion Criteria:

Patients that did not undergo cardiovascular surgeries and age\< 18 years old will be excluded from the study.

Where it's running

• University of California Davis Health System
  Sacramento, California, United States Recruiting

Study contacts

• Principal investigator: Hong Liu, M.D. — University of California, Davis, Department of Anesthesiology and Pain Medicine
• Study coordinator: Hong Liu, M.D.
• Email: hualiu@ucdmc.ucdavis.edu
• Phone: 916-734-2949

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Coronary CT angiography–guided calcium modification during PCI for calcified coronary artery disease

  This study will see if using CT angiography to plan calcium treatment before stenting helps people with flow-limiting, calcified coronary artery disease have better stent results and faster procedures compared with the usual ultrasound-guided PCI while keeping similar safety.

  Recruiting at 10 sites Fundación EPIC · Boston, Massachusetts and 14 other locations · NCT07286578

• Freesolve resorbable magnesium scaffold vs. Xience stent for up to two new heart artery lesions

  This trial tests whether the Freesolve resorbable magnesium scaffold works as well as the Xience drug-eluting stent for treating up to two new coronary artery lesions in adults.

  Recruiting at 3 sites Teleflex · Washington D.C., District of Columbia and 2 other locations · NCT07258290

• Intrapleural ropivacaine after heart surgery

  This study will test whether putting ropivacaine into the pleural space through chest drains reduces pain and improves recovery for adults after heart surgery.

  Recruiting at 2 sites Phase 4 Saint Petersburg State University, Russia · Saint Petersburg and 1 other locations · NCT07116343

• Short-term high-dose rosuvastatin effects on coronary plaque using photon-counting CT

  This trial tests whether a short course of intensified rosuvastatin (40 mg) changes coronary plaque composition and flow on photon‑counting coronary CT in statin‑naive adults with stable chest pain and mild atherosclerosis.

  Recruiting Semmelweis University · Budapest, Budapest · NCT06603363

• Single versus dual antiplatelet therapy after drug-coated balloon angioplasty in elderly or high-bleeding-risk patients

  This study tests whether taking one antiplatelet medicine is as safe and causes less bleeding than taking two medicines for people aged 75 or older, or adults at high bleeding risk, after drug-coated balloon angioplasty for coronary artery disease.

  Recruiting Fondazione Ricerca e Innovazione Cardiovascolare ETS · Milan, MI · NCT06535568

• μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease

  This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.

  Recruiting Centro Cardiologico Monzino · Cosenza, CS and 3 other locations · NCT07917234

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.